Skip to content
10-Q

Quarterly Report

Disc Medicine, Inc. IRON

0001193125-26-205192

← back to feed
Filed
May 5, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2026 · Apr 30, 2026 38.2M sh
Shares Diluted Q1 2026 · Mar 31, 2026 38.49M sh
Shares Diluted Q1 2026 · Mar 31, 2025 33.32M sh
Capex Q1 2026 · Mar 31, 2026 $0
Capex Q1 2026 · Mar 31, 2025 $851K
Operating Cash Flow Q1 2026 · Mar 31, 2026 −$62.24M
Operating Cash Flow Q1 2026 · Mar 31, 2025 −$41.38M
Long Term Debt Q1 2026 · Mar 31, 2026 $29.37M
Long Term Debt Q1 2026 · Dec 31, 2025 $29.16M
Cash And Equivalents Q1 2026 · Mar 31, 2026 $88.91M
Cash And Equivalents Q1 2026 · Dec 31, 2025 $91.15M
Stockholders Equity Q1 2026 · Mar 31, 2026 $688.43M
Stockholders Equity Q1 2026 · Dec 31, 2025 $739.83M
Stockholders Equity Q1 2026 · Mar 31, 2025 $660.36M
Stockholders Equity Q1 2026 · Dec 31, 2024 $443.59M
Current Liabilities Q1 2026 · Mar 31, 2026 $31.14M
Current Liabilities Q1 2026 · Dec 31, 2025 $36.64M
Total Liabilities Q1 2026 · Mar 31, 2026 $61.78M
Total Liabilities Q1 2026 · Dec 31, 2025 $67.05M
Current Assets Q1 2026 · Mar 31, 2026 $747.46M
Current Assets Q1 2026 · Dec 31, 2025 $803.9M
Total Assets Q1 2026 · Mar 31, 2026 $750.21M
Total Assets Q1 2026 · Dec 31, 2025 $806.88M
Eps Diluted Q1 2026 · Mar 31, 2026 −$1.65
Eps Diluted Q1 2026 · Mar 31, 2025 −$1.02
Eps Basic Q1 2026 · Mar 31, 2026 −$1.65
Eps Basic Q1 2026 · Mar 31, 2025 −$1.02
Sga Expense Q1 2026 · Mar 31, 2026 $23.62M
Sga Expense Q1 2026 · Mar 31, 2025 $12.18M
Rd Expense Q1 2026 · Mar 31, 2026 $45.9M
Rd Expense Q1 2026 · Mar 31, 2025 $27.76M
Net Income Q1 2026 · Mar 31, 2026 −$63.5M
Net Income Q1 2026 · Mar 31, 2025 −$34.09M
Operating Income Q1 2026 · Mar 31, 2026 −$69.52M
Operating Income Q1 2026 · Mar 31, 2025 −$39.95M